Review - Access to health care  - Pharmacologic prevention of migraine

20.500.12592/6rf2b2

Review - Access to health care - Pharmacologic prevention of migraine

27 Jan 2023

The goal of preventive treatment for migraine is to reduce the fre- Mindfulness-based therapies have also been studied and found to be quency, severity, duration and disability of attacks, and improve promising (Appendix 1, available at www.cmaj.ca/lookup/ response to and minimize use of acute medications. [...] *Levels of evidence using the GRADE system: high = the guideline authors are confident that the true effect lies close to the estimate given by the evidence available; moderate = the guideline authors are moderately confident in the effect estimate, but there is a possibility it is substantially different; low = the confidence in the effect estimate is limited. [...] Primary care *Levels of evidence using the GRADE system: high = the guideline authors are confident that the true effect lies close to the estimate given by the evidence available; practitioners may consider referral to a neurologist or headache moderate = the guideline authors are moderately confident in the effect estimate, but there is a possibility it is substantially different; low = the conf. [...] Fremanezumab for the preventive board of Migraine Canada and on the board of the Pain Society of treatment of chronic migraine. [...] Eptinezumab for the prevention of episodic migraine: sustained effect through 1 year of treatment in the Contributors: All of the authors contributed to the conception and PROMISE-1 study.
Pages
6
Published in
Canada

Tables